MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

MDT

97.77

-0.86%↓

A

142.24

-2.54%↓

VEEV

218.84

-0.76%↓

HQY

85.82

-1.36%↓

NEOG

9.39

-1.88%↓

Search

Glaukos Corp

Open

SectorHealthcare

115.46 10.31

Overview

Share price change

24h

Current

Min

108.68

Max

115.18

Key metrics

By Trading Economics

Income

3.4M

-16M

Sales

9.4M

134M

EPS

-0.16

Profit margin

-12.155

Employees

995

EBITDA

8.1M

-570K

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.71% upside

Dividends

By Dow Jones

Next Earnings

17 Feb 2026

Market Stats

By TradingEconomics

Market Cap

2B

6.4B

Previous open

105.15

Previous close

115.46

News Sentiment

By Acuity

43%

57%

144 / 361 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Glaukos Corp Chart

Past performance is not a reliable indicator of future results.

Related News

15 Jan 2026, 18:44 UTC

Major Market Movers

Agenus Falls After $141 Million Zydus Deal Closes

15 Jan 2026, 17:51 UTC

Major Market Movers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 Jan 2026, 17:25 UTC

Major Market Movers

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 Jan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Jan 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 Jan 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 Jan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15 Jan 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 Jan 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15 Jan 2026, 22:56 UTC

Market Talk
Earnings

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 Jan 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 Jan 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 Jan 2026, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 Jan 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Energy & Utilities Roundup: Market Talk

15 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 Jan 2026, 21:27 UTC

Earnings

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 Jan 2026, 21:15 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Commodities Roundup: Market Talk

15 Jan 2026, 21:11 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

15 Jan 2026, 21:11 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 Jan 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 Jan 2026, 20:04 UTC

Earnings

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 Jan 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 Jan 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15 Jan 2026, 18:29 UTC

Major Market Movers

Agenus Falls After $141M Zydus Deal Closes

15 Jan 2026, 18:20 UTC

Earnings

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 Jan 2026, 17:56 UTC

Market Talk
Earnings

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 Jan 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Auto & Transport Roundup: Market Talk

15 Jan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 Jan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 Jan 2026, 17:02 UTC

Acquisitions, Mergers, Takeovers

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Peer Comparison

Price change

Glaukos Corp Forecast

Price Target

By TipRanks

15.71% upside

12 Months Forecast

Average 127.55 USD  15.71%

High 165 USD

Low 72 USD

Based on 14 Wall Street analysts offering 12 month price targets forGlaukos Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

13

Buy

0

Hold

1

Sell

Technical Score

By Trading Central

87.61 / 93Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

144 / 361 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat